CSBR
Price:
$4.25
Market Cap:
$57.77M
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. The company provides Lumin Bioinformatics, a software pla...[Read more]
Industry
Biotechnology
IPO Date
2007-02-02
Stock Exchange
NASDAQ
Ticker
CSBR
According to Champions Oncology, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -7.87. This represents a change of -82.16% compared to the average of -44.12 of the last 4 quarters.
The mean historical PE Ratio of Champions Oncology, Inc. over the last ten years is 126.74. The current -7.87 PE Ratio has changed -720.96% with respect to the historical average. Over the past ten years (40 quarters), CSBR's PE Ratio was at its highest in in the October 2020 quarter at 28.68K. The PE Ratio was at its lowest in in the October 2022 quarter at -1467.01.
Average
126.74
Median
-4.46
Minimum
-46.29
Maximum
804.44
Discovering the peaks and valleys of Champions Oncology, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 675.62%
Maximum Annual PE Ratio = 804.44
Minimum Annual Increase = -2640.87%
Minimum Annual PE Ratio = -46.29
Year | PE Ratio | Change |
---|---|---|
2024 | -9.03 | -26.79% |
2023 | -12.34 | -106.67% |
2022 | 184.95 | -52.51% |
2021 | 389.45 | -941.25% |
2020 | -46.29 | -105.75% |
2019 | 804.44 | -2640.87% |
2018 | -31.66 | 675.62% |
2017 | -4.08 | 27.37% |
2016 | -3.20 | -33.89% |
2015 | -4.85 | -41.00% |
The current PE Ratio of Champions Oncology, Inc. (CSBR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
54.53
5-year avg
101.35
10-year avg
126.74
Champions Oncology, Inc.’s PE Ratio is less than Molecular Partners AG (-2.67), greater than MediciNova, Inc. (-12.61), less than Anebulo Pharmaceuticals, Inc. (-4.99), less than Cyteir Therapeutics, Inc. (-3.52), less than Pardes Biosciences, Inc. (-1.36), less than Shattuck Labs, Inc. (-2.08), less than Eliem Therapeutics, Inc. (-3.49), less than Century Therapeutics, Inc. (-0.91), less than Aerovate Therapeutics, Inc. (-0.62), less than Adagene Inc. (-2.86), less than Acrivon Therapeutics, Inc. Common Stock (-4.23), less than Rezolute, Inc. (-3.80), less than AN2 Therapeutics, Inc. (-0.47), less than HCW Biologics Inc. (-0.69),
Company | PE Ratio | Market cap |
---|---|---|
-2.67 | $182.90M | |
-12.61 | $103.00M | |
-4.99 | $46.68M | |
-3.52 | $108.71M | |
-1.36 | $135.19M | |
-2.08 | $167.05M | |
-3.49 | $495.57M | |
-0.91 | $123.69M | |
-0.62 | $54.85M | |
-2.86 | $115.55M | |
-4.23 | $250.26M | |
-3.80 | $240.80M | |
-0.47 | $30.44M | |
-0.69 | $26.62M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Champions Oncology, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Champions Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Champions Oncology, Inc.'s PE Ratio?
How is the PE Ratio calculated for Champions Oncology, Inc. (CSBR)?
What is the highest PE Ratio for Champions Oncology, Inc. (CSBR)?
What is the 3-year average PE Ratio for Champions Oncology, Inc. (CSBR)?
What is the 5-year average PE Ratio for Champions Oncology, Inc. (CSBR)?
How does the current PE Ratio for Champions Oncology, Inc. (CSBR) compare to its historical average?